miR-124 upregulation as a new therapeutic strategy: The evolving role of obefazimod in ulcerative colitis

Viviana Parra-Izquierdo, Virginia Solitano, Bram Verstockt
Current Opinion in Pharmacology · Elsevier · 2026-12-01 · DOI: 10.1016/j.coph.2026.102659

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles